Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

发表于半小时前

期刊：European Journal of Cancer

文献作者：Chunmei Bai; Yi Zheng; Meili Sun; Jieer Ying; Fuxiang Zhou; Yiyi Yu; Ligang Xing; Yanqiao Zhang; Jinhua Wen; Heshui Wu; Xiuli Yang; Lixin Wan; Shiwei Guo; Rusen Zhao; Zhizhen Zhu; Wei Shen; Qi Wang; Shanzhi Gu; Hao Wu; Weichang Chen; Jin Xia; Jun Zhao; Xiaofang Dong; Wenhui Lou; Kuirong Jiang; Zhiye Zhang; Xiaobing Chen; Deliang Fu; Youshan Chen; Baoqing Wang; Jiaxin Liu; Yuan Ji; Shijie Yuan; Yuan Li; Zhihua Gong; Da Fei; Xia Qin; Crystal Qin; Jin Li

出版日期：2025-11-

DOI号：10.1016/j.ejca.2025.115808

下载链接：https://www.sciencedirect.com/sc ... 959804925005945/pdf

文献链接：https://doi.org/10.1016/j.ejca.2025.115808

当前文献来源于 Elsevier BV。

备注信息：

发表于 29 分钟前

: 当前求助处于待确认状态,请尽快下载
如果48小时后该求助仍未采纳，系统将自动采纳。

[Elsevier/Sciencedirect] Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial 一键复制

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Elsevier/Sciencedirect] Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial